More issues

Getting Zanzalintinib (XL092) Covered by UnitedHealthcare in Pennsylvania: Clinical Trial Access and Compassionate Use Appeals Guide

Answer Box: Your Fastest Path to Zanzalintinib Coverage Getting Zanzalintinib (XL092) covered by UnitedHealthcare in Pennsylvania requires clinical trial enrollment or compassionate use approval, since this investigational TKI has no FDA approval. Your three options: (1) Enroll in an active STELLAR program trial where UnitedHealthcare covers routine monitoring costs, (2)
6 min read

How to Get Fintepla (fenfluramine) Covered by Blue Cross Blue Shield in Washington: Appeals Process, REMS Requirements, and State Protections

Answer Box: Getting Fintepla Covered by Blue Cross Blue Shield in Washington Fintepla (fenfluramine) requires prior authorization from Blue Cross Blue Shield with mandatory REMS enrollment and baseline echocardiography. To get approval: (1) Complete REMS enrollment at FinteplaREMS.com with baseline ECHO, (2) Submit PA with diagnosis confirmation (Dravet G40.
6 min read

How to Get Rezlidhia (Olutasidenib) Covered by UnitedHealthcare in New York: Prior Authorization Guide

Answer Box: Getting Rezlidhia Covered by UnitedHealthcare in New York Rezlidhia (olutasidenib) requires prior authorization from UnitedHealthcare OptumRx in New York. You'll need documented IDH1 mutation results, confirmed relapsed/refractory AML diagnosis, and evidence of prior therapy failures. Submit through the UnitedHealthcare Provider Portal with complete documentation for
6 min read

How to Get Gamifant (Emapalumab-lzsg) Covered by Blue Cross Blue Shield in Pennsylvania: Complete Timeline and Appeal Guide

Answer Box: Getting Gamifant Covered by Blue Cross Blue Shield in Pennsylvania Blue Cross Blue Shield requires prior authorization for Gamifant (emapalumab-lzsg) with documented HLH diagnosis using 5 of 8 HLH-2004 criteria OR genetic confirmation, plus failure/intolerance to conventional therapy (etoposide, dexamethasone, cyclosporine). Standard PA decisions take 14-30 days;
5 min read

How to Get Onivyde (Irinotecan Liposome) Covered by Humana in Michigan: Forms, Appeals, and Provider Resources

Answer Box: Getting Onivyde Covered by Humana in Michigan Onivyde (irinotecan liposome) is covered by Humana Medicare Advantage plans in Michigan for FDA-approved metastatic pancreatic adenocarcinoma, but requires prior authorization. The fastest path: verify your oncologist is in-network, gather complete clinical documentation (pathology, ECOG status, prior therapies), and submit Humana&
5 min read

How to Get Ultomiris (Ravulizumab) Covered by UnitedHealthcare in Ohio: Prior Authorization, Appeals, and Step Therapy Override Guide

Answer Box: Getting Ultomiris Approved by UnitedHealthcare in Ohio UnitedHealthcare requires prior authorization for Ultomiris (ravulizumab) with step therapy typically requiring eculizumab (Soliris) first. Submit PA through OptumRx (1-800-711-4555) or UnitedHealthcare provider portal. If denied, request peer-to-peer review within one business day, then file internal appeal within 180 days. Ohio
6 min read